Current Status of Antimicrobial Sensitivity Pattern of <i>Streptococcus pneumonia</i> Strains Collected from Clinical Sources in Dhaka, Bangladesh
AbstractA study of antimicrobial sensitivity of Streptococcus pneumoniae strains from clinical specimens was carried out to facilitate the preference of antimicrobial drugs in the management of S. pneumoniae induced infections. The duration of the study was about 12 months starting from March 2009 to March 2010. The results of the study show that tetracycline and chloramphenicol had a low sensitivity (20% and 22%, respectively) to S. pneumoniae while a moderate sensitivity was found for azithromycin (50%), erythromycin (54%), cotrimoxazole (58%), cefuroxime (62%), and cefaclor (62%). However, the highest sensitivity was observed for ceftriaxone (92%) followed by levofloxacin (74%) and ceftazidime (70%). This study reveals the growing antimicrobial resistance in Bangladesh and refers not to use the antimicrobial drugs that show insufficient sensitivity against S. pneumoniae to prevent resistance and associated treatment failure.
Key words: Streptococcus pneumoniae; antimicrobial sensitivity; clinical isolates.
S. J. Pharm. Sci. 3(1): 59-62
Each author must agree to this statement
Authorship: This manuscript is the original work of the authors, each of whom has read and approved of the work. Each author satisfied the requirements contained in 'Author Guidelines' having participated sufficiently in the work to take public responsibility for the content. This participation includes:
- Conception or design of the study, or analysis and interpretation of data, or both
- Drafting the article or revising it for critically important intellectual content
- Approval of the final 'to be published' version
All authors must take responsibility for the integrity of the work. Participating solely in the collection of data does not justify authorship.
Prior publication: This work is not currently under consideration by any other journal. Information about prior publication of any part of this work, or inclusion of patients detailed herein in any other work, has been provided in the cover letter.
Conflict of interest: Details of any financial or other relationship between any author and any other party that may lead to a conflict of interest with the subject or any materials mentioned in this article have been disclosed in the cover letter.